Yoko Franchetti

1.1k total citations
13 papers, 341 citations indexed

About

Yoko Franchetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Yoko Franchetti has authored 13 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Yoko Franchetti's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Yoko Franchetti is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Yoko Franchetti collaborates with scholars based in United States and Japan. Yoko Franchetti's co-authors include Thomas D. Nolin, Paul J. Catalano, Michael A. Maddaus, Alberto de Hoyos, Ninh T. Nguyen, Arjun Pennathur, David J. Sugarbaker, James D. Luketich, Scott J. Swanson and Al B. Benson and has published in prestigious journals such as Cancer, Annals of Surgery and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yoko Franchetti

12 papers receiving 337 citations

Peers

Yoko Franchetti
Yoko Franchetti
Citations per year, relative to Yoko Franchetti Yoko Franchetti (= 1×) peers Uğur Üyetürk

Countries citing papers authored by Yoko Franchetti

Since Specialization
Citations

This map shows the geographic impact of Yoko Franchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Franchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Franchetti more than expected).

Fields of papers citing papers by Yoko Franchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Franchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Franchetti. The network helps show where Yoko Franchetti may publish in the future.

Co-authorship network of co-authors of Yoko Franchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Franchetti. A scholar is included among the top collaborators of Yoko Franchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Franchetti. Yoko Franchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kamal, Mohamed, Yoko Franchetti, Christine Xu, et al.. (2021). Pharmacokinetics and Concentration‐Response of Dupilumab in Patients With Seasonal Allergic Rhinitis. The Journal of Clinical Pharmacology. 62(5). 689–695. 7 indexed citations
3.
Franchetti, Yoko & Thomas D. Nolin. (2021). Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance Pathways. The Journal of Clinical Pharmacology. 61(6). 769–781.
4.
Franchetti, Yoko & Thomas D. Nolin. (2020). Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation. The Journal of Clinical Pharmacology. 60(S1). S36–S51. 18 indexed citations
5.
Franchetti, Yoko & Thomas D. Nolin. (2019). Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of 14CO2 Production Rate Data. Journal of Pharmacology and Experimental Therapeutics. 371(1). 151–161. 2 indexed citations
6.
Stubbs, Jason R., Margaret Stedman, Sai Liu, et al.. (2019). Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis. Clinical Journal of the American Society of Nephrology. 14(2). 261–267. 56 indexed citations
7.
Jacene, Heather A., Pamela J. DiPiro, Jiani Hu, et al.. (2018). Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade. Clinical Breast Cancer. 19(2). 146–155. 3 indexed citations
8.
Luketich, James D., Arjun Pennathur, Yoko Franchetti, et al.. (2015). Minimally Invasive Esophagectomy. Annals of Surgery. 261(4). 702–707. 147 indexed citations
11.
Franchetti, Yoko, Stewart Anderson, & Allan R. Sampson. (2013). An Adaptive Two-Stage Dose-Response Design Method for Establishing Proof of Concept. Journal of Biopharmaceutical Statistics. 23(5). 1124–1154. 6 indexed citations
13.
Jacene, Heather A., Pamela J. DiPiro, Jennifer R. Bellon, et al.. (2013). Is SUVmax in baseline PET/CT scans of patients with inflammatory breast cancer (IBC) associated with a complete pathologic response in mastectomy tissue after neoadjuvant chemotherapy?. 54. 124–124. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026